Brief: Asit Biotech Publishes Phase IIb Clinical Results With gp-ASIT+

European Medical Solutions SA

30/11/2017 18:27

Nov 30 (Reuters) - ASIT BIOTECH SA  ASIT.BR : 
    * ASIT BIOTECH: NEWLY PUBLISHED PHASE IIB CLINICAL RESULTS 
WITH 
GP-ASIT+ IN THE ALLERGY JOURNAL HIGHLIGHT OUTSTANDING CLINICAL 
AND REMARKABLE IMMUNOLOGICAL EFFECTS 
    * STUDY RESULTS ALSO CONFIRMED THAT GP-ASIT+ IS SAFE AND 
WELL 
TOLERATED 
    * CLINICAL AND IMMUNOLOGICAL EFFECTS OBSERVED IN THIS PHASE 
IIB 
HAVE BEEN CONFIRMED IN FIRST PHASE III 
    * RESULTS OF THIS PHASE III TRIAL WILL BE PUBLISHED SOON IN 
A 
PEER-REVIEWED JOURNAL 
 
Source text for Eikon:  ID:nBw3zrTYSa  
Further company coverage:  ASIT.BR  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))